| Previous Close | 47.500 |
| Open | 47.110 |
| Bid | 46.560 x 100 |
| Ask | 46.570 x 400 |
| Day's Range | 46.540 - 47.250 |
| 52 Week Range | 20.000 - 47.950 |
| Volume | 802,065 |
| Avg. Volume | 3,819,992 |
| Market Cap | 8.6B |
| Beta | N/A |
| PE Ratio (TTM) | 53.08 |
| EPS (TTM) | 0.88 |
| Earnings Date | Jan 9, 2017 - Jan 13, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 46.92 |
- Zacks•yesterday
Alcoa, Cheesecake Factory, Luminex, Ligand Pharmaceuticals and Centene highlighted as Zacks Bull and Bear of the Day
Alcoa, Cheesecake Factory, Luminex, Ligand Pharmaceuticals and Centene highlighted as Zacks Bull and Bear of the Day
- Barrons.com•yesterday
[$$] Alcoa May Have a Strong Q3
Alcoa (AA:NYSE) By Morgan Stanley ($44.91, Sept. 19, 2017) We have raised our third-quarter estimated earnings before interest, taxes, depreciation and amortization (Ebitda) for Alcoa to $532 million and earnings-per-share estimate to 80 cents, and our estimates are now above the Street. Alcoa (AA) could beat our third-quarter estimates on lower energy costs or higher energy sales.
